Bristol-Myers (BMY) Announces Expiration of HSR Waiting Period in ZymoGenetics (ZGEN) Tender
Bristol-Myers Squibb Company (NYSE: BMY) announced that the expiration of the Hart-Scott-Rodino (HSR) waiting period for its tender offer for ZymoGenetics, Inc. (Nasdaq: ZGEN).
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Bazaarvoice (BV) Agrees to Buy PowerReviews; Offers Prelim. Q1 Results, Guides Q2, FY13
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
- Sony (SNE) Said to Pay for 3-D Glasses for 'Men In Black 3' -Bloomberg (RLD)
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
ZymoGenetics/Bristol-Myers SquibbSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
